HRP20141081T1 - Tikagrelor za lijeäśenje aneurizme abdominalne aorte - Google Patents
Tikagrelor za lijeäśenje aneurizme abdominalne aorte Download PDFInfo
- Publication number
- HRP20141081T1 HRP20141081T1 HRP20141081AT HRP20141081T HRP20141081T1 HR P20141081 T1 HRP20141081 T1 HR P20141081T1 HR P20141081A T HRP20141081A T HR P20141081AT HR P20141081 T HRP20141081 T HR P20141081T HR P20141081 T1 HRP20141081 T1 HR P20141081T1
- Authority
- HR
- Croatia
- Prior art keywords
- treatment
- ticagrelor
- abdominal aortic
- aortic aneurysms
- abdominal
- Prior art date
Links
- 208000002223 abdominal aortic aneurysm Diseases 0.000 title claims 2
- OEKWJQXRCDYSHL-FNOIDJSQSA-N ticagrelor Chemical compound C1([C@@H]2C[C@H]2NC=2N=C(N=C3N([C@H]4[C@@H]([C@H](O)[C@@H](OCCO)C4)O)N=NC3=2)SCCC)=CC=C(F)C(F)=C1 OEKWJQXRCDYSHL-FNOIDJSQSA-N 0.000 title 1
- 229960002528 ticagrelor Drugs 0.000 title 1
- 208000007474 aortic aneurysm Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- VCVOSERVUCJNPR-UHFFFAOYSA-N cyclopentane-1,2-diol Chemical compound OC1CCCC1O VCVOSERVUCJNPR-UHFFFAOYSA-N 0.000 claims 2
- 210000000709 aorta Anatomy 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (2)
1. Uporaba spoja {1S-[1α,2α,3β(1S*,2R*),5β]}-3-(7-{[2-(3,4-difluorofenil)ciklopropil]amino}-5-(propiltio)-3H-1,2,3-triazolo[4,5-d]pirimidin-3-il)-5-(2-hidroksietoksi)ciklopentan-1,2-diola naznačena time da je za proizvodnju lijeka za liječenje aneurizme abdominalne aorte.
2. Spoj {1S-[1α,2α,3β(1S*,2R*),5β]}-3-(7-{[2-(3,4-difluorofenil)ciklopropil]amino}-5-(propiltio)-3H-1,2,3-triazolo[4,5-d]pirimidin-3-il)-5-(2-hidroksietoksi)ciklopentan-1,2-diola naznačen time da je za uporabu za liječenje aneurizme abdominalne aorte.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07301616 | 2007-12-03 | ||
| PCT/SE2008/051386 WO2009072967A1 (en) | 2007-12-03 | 2008-12-02 | Triazolo [4,5-d] pyrimidine compounds for treatment of abdominal aortic aneurysms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20141081T1 true HRP20141081T1 (hr) | 2015-01-02 |
Family
ID=40717966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20141081AT HRP20141081T1 (hr) | 2007-12-03 | 2014-11-05 | Tikagrelor za lijeäśenje aneurizme abdominalne aorte |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US20100298350A1 (hr) |
| EP (1) | EP2229172B1 (hr) |
| JP (1) | JP5701060B2 (hr) |
| KR (1) | KR101563757B1 (hr) |
| CN (2) | CN101883565A (hr) |
| AU (1) | AU2008331984B2 (hr) |
| BR (1) | BRPI0819458A2 (hr) |
| CA (1) | CA2707488C (hr) |
| CY (1) | CY1115760T1 (hr) |
| DK (1) | DK2229172T3 (hr) |
| EA (1) | EA201000928A1 (hr) |
| ES (1) | ES2522317T3 (hr) |
| HK (1) | HK1148195A1 (hr) |
| HR (1) | HRP20141081T1 (hr) |
| IL (1) | IL205613A (hr) |
| MX (1) | MX2010006101A (hr) |
| MY (1) | MY159656A (hr) |
| NZ (1) | NZ585513A (hr) |
| PL (1) | PL2229172T3 (hr) |
| PT (1) | PT2229172E (hr) |
| RS (1) | RS53635B1 (hr) |
| SI (1) | SI2229172T1 (hr) |
| UA (1) | UA100864C2 (hr) |
| WO (1) | WO2009072967A1 (hr) |
| ZA (1) | ZA201003599B (hr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102653539B (zh) * | 2011-03-01 | 2014-09-17 | 秦引林 | 一种抗血小板聚集化合物及其药物组合 |
| CN102924457A (zh) * | 2011-08-12 | 2013-02-13 | 上海恒瑞医药有限公司 | 三唑并嘧啶类衍生物、其制备方法及其用途 |
| EP2750676B1 (en) | 2011-08-30 | 2018-01-10 | University of Utah Research Foundation | Methods and compositions for treating nephrogenic diabetes insipidus |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9609467A (pt) * | 1995-07-11 | 1999-03-02 | Astra Pharma Prod | Composto uso de um composto composição farmacéutica e processos para preparação de um composto e tratamento de distúrbios de agregação planquetária |
| AR017014A1 (es) * | 1997-07-22 | 2001-08-22 | Astrazeneca Ab | Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos |
| TWI229674B (en) * | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
| GB0013407D0 (en) * | 2000-06-02 | 2000-07-26 | Astrazeneca Ab | Forms of a chemical compound |
| SE0101932D0 (sv) * | 2001-05-31 | 2001-05-31 | Astrazeneca Ab | Pharmaceutical combinations |
| WO2009007675A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist |
-
2008
- 2008-02-12 UA UAA201005772A patent/UA100864C2/uk unknown
- 2008-12-02 KR KR1020107013193A patent/KR101563757B1/ko active IP Right Grant
- 2008-12-02 MX MX2010006101A patent/MX2010006101A/es active IP Right Grant
- 2008-12-02 DK DK08857354.8T patent/DK2229172T3/da active
- 2008-12-02 EP EP08857354.8A patent/EP2229172B1/en active Active
- 2008-12-02 AU AU2008331984A patent/AU2008331984B2/en active Active
- 2008-12-02 SI SI200831311T patent/SI2229172T1/sl unknown
- 2008-12-02 EA EA201000928A patent/EA201000928A1/ru unknown
- 2008-12-02 RS RS20140600A patent/RS53635B1/en unknown
- 2008-12-02 US US12/745,733 patent/US20100298350A1/en not_active Abandoned
- 2008-12-02 MY MYPI2010002526A patent/MY159656A/en unknown
- 2008-12-02 JP JP2010536888A patent/JP5701060B2/ja active Active
- 2008-12-02 BR BRPI0819458 patent/BRPI0819458A2/pt not_active Application Discontinuation
- 2008-12-02 NZ NZ585513A patent/NZ585513A/en unknown
- 2008-12-02 PT PT88573548T patent/PT2229172E/pt unknown
- 2008-12-02 WO PCT/SE2008/051386 patent/WO2009072967A1/en active Application Filing
- 2008-12-02 CN CN2008801189070A patent/CN101883565A/zh active Pending
- 2008-12-02 ES ES08857354.8T patent/ES2522317T3/es active Active
- 2008-12-02 PL PL08857354T patent/PL2229172T3/pl unknown
- 2008-12-02 CA CA2707488A patent/CA2707488C/en not_active Expired - Fee Related
- 2008-12-02 CN CN201410139401.5A patent/CN103919781A/zh active Pending
-
2010
- 2010-05-06 IL IL205613A patent/IL205613A/en active IP Right Grant
- 2010-05-20 ZA ZA2010/03599A patent/ZA201003599B/en unknown
-
2011
- 2011-03-07 HK HK11102267.9A patent/HK1148195A1/xx unknown
-
2014
- 2014-10-30 CY CY20141100893T patent/CY1115760T1/el unknown
- 2014-11-05 HR HRP20141081AT patent/HRP20141081T1/hr unknown
-
2015
- 2015-01-15 US US14/597,255 patent/US20150272955A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011505417A (ja) | 2011-02-24 |
| ES2522317T3 (es) | 2014-11-14 |
| KR101563757B1 (ko) | 2015-10-27 |
| US20150272955A1 (en) | 2015-10-01 |
| EP2229172A1 (en) | 2010-09-22 |
| PL2229172T3 (pl) | 2015-01-30 |
| HK1148195A1 (en) | 2011-09-02 |
| BRPI0819458A2 (pt) | 2015-05-05 |
| KR20100099175A (ko) | 2010-09-10 |
| CN101883565A (zh) | 2010-11-10 |
| IL205613A (en) | 2015-04-30 |
| EP2229172A4 (en) | 2012-12-26 |
| EA201000928A1 (ru) | 2010-12-30 |
| AU2008331984A1 (en) | 2009-06-11 |
| MY159656A (en) | 2017-01-13 |
| CA2707488C (en) | 2015-07-28 |
| SI2229172T1 (sl) | 2014-12-31 |
| MX2010006101A (es) | 2010-10-04 |
| WO2009072967A1 (en) | 2009-06-11 |
| PT2229172E (pt) | 2014-11-03 |
| CA2707488A1 (en) | 2009-06-11 |
| NZ585513A (en) | 2012-07-27 |
| US20100298350A1 (en) | 2010-11-25 |
| RS53635B1 (en) | 2015-04-30 |
| EP2229172B1 (en) | 2014-09-10 |
| IL205613A0 (en) | 2010-11-30 |
| UA100864C2 (uk) | 2013-02-11 |
| CN103919781A (zh) | 2014-07-16 |
| DK2229172T3 (da) | 2014-11-10 |
| AU2008331984B2 (en) | 2012-08-16 |
| CY1115760T1 (el) | 2017-01-25 |
| ZA201003599B (en) | 2012-10-31 |
| JP5701060B2 (ja) | 2015-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL229130A0 (en) | A pharmaceutical preparation containing {1s–[1a,2a,3b(1s*,2r*),5b]}–3–(7–{[2–(3,4–difluorophenyl)cyclopropyl]amino}–5–(propylthio) -3h-1,2,3-triazolo[4,5-d]pyrimidin-3-yl)-5-hydroxyethoxy)cyclopentane-1,2-diol | |
| HRP20141081T1 (hr) | Tikagrelor za lijeäśenje aneurizme abdominalne aorte | |
| CY1122575T1 (el) | Φαρμακοτεχνικες μορφες διστρωματικου δισκιου | |
| CY1117815T1 (el) | Τοπικο σκευασμα για εναν αναστολεα jak | |
| CL2011002956A1 (es) | Compuestos derivados de pirrolo[2,3-d]pirimidina, inhibidores de la quinasa janus (jak1); composicion farmaceutica; y uso para el tratamiento de una enfermedad autoinmune, cancer, trastorno mieloproliferativo, una enfermedad inflamatoria o rechazo de trasplante de organos. | |
| SI2644591T1 (en) | Optically active intermediate 2-aryl cyclopropane carboxamide | |
| CL2015000428A1 (es) | Uso de un anticuerpo inhibidor de la dimerización de her2 para preparar medicamento para extender el tiempo de progresion de una enfermedad (ttp) o supervivencia en un paciente con cancer de mama metastasico (mbc) (div. sol. n°399-06). | |
| DOP2018000203A (es) | Profármaco de adrenomedulina basado en polietilenglicol y su uso | |
| CR11854A (es) | Compuestos de piridina | |
| IL211191A0 (en) | A process for preparing[1s- [1-alpha, 2-alpha, 3-beta (1s*, 2r*) 5-beta]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3h-1, 2,3-triazolo [4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol and to its intermediates | |
| ECSP099250A (es) | USO DE 2-6-(3-amino-piperidin-1-Il)-3-metil-2,4-dioxo-3,4-dihIdro-2H-pIrimidin-1-IlmetIL-4-fluoro-benzonitrilo | |
| ECSP14007473A (es) | COMPOSICIONES FARMACÉUTICAS DE 7-(6-(2-HIDROXIPROPAN-2-IL) PIRIDIN-3-IL)-1-( (TRANS)-4METOXICICLOHEXIL)-3, 4-DIHIDROPIRAZINO [2, 3-b] PIRAZIN-2 (1H)-ONA, UNA FORMA SÓLIDA DE LAS MISMAS Y MÉTODOS DE SU USO | |
| CL2013000933A1 (es) | Compuestos derivados de furo[3,2-d]pirimidina y sus sales; composicion farmaceutica que los comprende; y su uso para tratar una afeccion que esta mediada por la actividad de una proteina quinasa, tal como cancer, trastornos cardiovasculares, del snc e inmunes, y enfermedades relacionadas con la inmunodeficiencia adquirida. | |
| CL2011002972A1 (es) | Compuestos derivados de imidazol sustituido, moduladores de la actividad de receptores x del higado (lxr); composicion farmaceutica, utiles en el tratamiento de trastornos como aterosclerosis, resistencia a la insulina, artrosis, diabetes, enfermedad de alzheimer, entre otras. | |
| PA8635301A1 (es) | Derivados sustituidos del dioxido de oxazolbenzoisotiazol, procedimiento para su preparacion y su uso | |
| AR069325A1 (es) | Proceso para preparar sales de dibenzoil - l - tartrato | |
| UY29009A1 (es) | Nuevos derivados de pirimidina, sales y solvatos farmaccuticamente aceptables de los mismos, composiciones, procedimientos para su preparacinn y uso. | |
| CO2018012431A2 (es) | Comprimidos de disgregación oral | |
| CR11591A (es) | Pirimidil ciclopentanos hidroxilados en forma de inhibidores de akt proteina quinasa | |
| BRPI1015943A8 (pt) | derivados de 1,2,3,4-tetra - hidro - pirimido {1,2-a} pirimidin-6-ona, o respectivo preparo e a respectiva utilização farmacêutica. | |
| CL2019002318A1 (es) | Administración subcutánea de un antagonista del receptor p2y12. | |
| IT1399764B1 (it) | Procedimento per la sintesi di 4h-imidazo [1,5-a][1,4]benzodiazepine, in particolare di midazolam. | |
| UY30880A1 (es) | 7-alcoxicinolin-3-carboxamidas sustituidas y sales farmacéuticamente aceptables de las mismas, procedimientos de preparacion y aplicaciones | |
| SI3596080T1 (sl) | Farmakološko aktivni aliciklični-substituirani pirazolo-(1,5-a)pirimidinski derivati | |
| PA8793401A1 (es) | Nuevos tetrahidronaftalenos sustituidos, procedimiento para su preparación y uso de los mismos como medicamentos |